IL13 and Alzheimer disease: Skin-derived AMPs such as hBD-2 and LL-37 have been shown to increase the expression of proinflammatory cytokines, including IL-4, IL-13, and IL-31 by T cells and mast cells, which are characteristic of AD pathology [36,69].